On February 26, Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Hutchison Whampoa traditional Chinese Medicine Co., Ltd., a subsidiary of Guangzhou Pharmaceutical Group, officially started the construction of phase I project of Chinese patent medicine intelligent manufacturing and warehousing logistics platform in Guangzhou Pharmaceutical Industrial Park, Zhongluotan Town, Baiyun District. The project is constructed in two phases. The total investment of phase I project is about 290 million yuan, with a construction period of two years. It is planned to be officially put into use by the end of 2024. In the future, the project will become a benchmark base for intelligent manufacturing of Chinese patent medicine in the industry and an industry-leading drug storage and logistics platform.
© China Stock Market News